The Causes and Implications of Glass Delamination - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Causes and Implications of Glass Delamination
This article focuses on the history of glass delamination and methods that detect it, both from a compendial and a research perspective.


Pharmaceutical Technology
pp. s6-s9

The appearance of visible flakes or glass lamellae in various pharmaceutical products contained in vials has sparked a series of product recalls over the past 18 months and initiated an industrywide conversation about the assessment of glass quality for pharmaceutical applications. Recent FDA communications have recommended that all pharmaceutical companies renew conversations with their suppliers on the topic of glass quality to ensure that patient safety and product quality are not compromised when a glass vial, cartridge, or syringe is the primary packaging component (1).

Several recent studies in the pharmaceutical industry have examined the causes of and factors that influence glass delamination. They recommended analytical tests that can assess the propensity of a pharmaceutical liquid to react with its primary glass container (2–4). Glass delamination, however, is not a new phenomenon. In 1953, Dimbleby recognized the seriousness of glass flakes in pharmaceutical products and prescribed a series of tests that could measure glass durability (5–8). According to Dimbleby, visual inspection to monitor the presence of glass flakes should not be the sole test for assessing glass–product compatibility.

A review of the glass-science literature reveals that the reaction of water and glass has been observed for nearly three centuries and has long been recognized as a problem in the preservation of glass antiquities (9–11). When glass surfaces are exposed to water, the network-forming oxides, such as silicone oxide (i.e., silica), leach from the surface, thus resulting in a glass chemistry that exhibits less resistance to chemical attack. This glass layer, which has different mechanical properties than the bulk substrate, will form flakes and spall (2, 3, 10). Corrosion mechanisms for glass are well identified (12–15). White identified six specific mechanisms of corrosion (15). The mechanism that best describes glass delamination, or weathering, is incongruent dissolution with the formation of noncrystalline layers. During this process, the gel layer of the glass that exists in the presence of water dries out and forms a pattern of cracks.


Figure 1: Scanning electron micrographs that show evidence of glass–liquid interaction, including a) a vial interior that has undergone delamination and shows signs of aggressive attack, and b) signs of modest glass-liquid interaction. No visible flakes were ever observed in the liquid. (ALL FIGURES ARE COURTESY OF THE AUTHOR)
Figure 1 shows images obtained from the interior of glass vials. Dimbleby and Iacocca identified some of the factors that affect the durability of pharmaceutical glass, including the following:
  • Terminal sterilization by autoclaving
  • Thermal exposure during vial formation
  • Glass chemistry
  • Surface treatment, such as acid washing or ammonium-sulfate treatment
  • The chemical nature of the liquid (3, 5, 7).

Currently, visual inspection has been the dominant technique to detect the presence of glass lamellae. The visualization of flakes, however, is the last step in the delamination process. It is a lagging analytical indicator for a chemical incompatibility between the exposed glass surface and its environment. As long ago as 1935, Dimbleby recognized that visual observations of glass flakes were not sufficient. He recommended chemical analysis of the liquid in question for various factors, including alkaline content, dissolved elements from the glass, and shifts in pH. With the development of electron microscopy, surface analytical techniques, and quantitative analytical instrumentation, the titration techniques suggested by Dimbleby have been augmented.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here